Pfizer Inc PFE:NYSE (Common Stock)

LastDaily Change / % ChangeDividend YieldVolumeAvg Volume (10 day)
33.86 0.01   0.03%3.78%14,832,19719.5M
Market data is delayed by at least 15 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 4/27/2017

Latest News Headlines for Pfizer Inc

(CNCN) InSphero annonce un accord avec Pfizer visant à développer de nouveaux tests pour la prédiction des lésions hépatiques induites par les médicaments

InSphero annonce un accord avec Pfizer visant à développer de nouveaux tests pour la prédiction des lésions hépatiques induites par les médicaments Leurs efforts de recherche utiliseront les micro-tissus de foie humain InSphero 3D InSight(TM) afin de développer de nouveaux tests visant à prédire et évaluer certains mécanismes à l'origine des lésions hépatiques induites par les médicaments (LHIM)

InSphero annonce un accord avec Pfizer visant à développer de nouveaux tests pour la prédiction des lésions hépatiques induites par les médicaments

InSphero annonce un accord avec Pfizer visant à développer de nouveaux tests pour la prédiction des lésions hépatiques induites par les médicaments Leurs efforts de recherche utiliseront les micro-tissus de foie humain InSphero 3D InSight(TM) afin de développer de nouveaux tests visant à prédire et évaluer certains mécanismes à l'origine des lésions hépatiques induites par les médicaments (LHIM)

InSphero anuncia acuerdo con Pfizer para desarrollar nuevos ensayos para predecir lesiones hepáticas inducidas por fármacos

InSphero anuncia acuerdo con Pfizer para desarrollar nuevos ensayos para predecir lesiones hepáticas inducidas por fármacos El trabajo de investigación utilizará microtejidos hepáticos humanos InSphero 3D InSight(TM) para desarrollar nuevos ensayos que permitan predecir y evaluar ciertos mecanismos que causan lesiones hepáticas inducidas por fármacos (DILI)

View more recent headlines

Peers Information HelpPFE Pfizer Inc vs. Peers

PFE
Pfizer Inc
4.25%
Novartis AG (ADR)
5.79%
Roche Holding Ltd. (ADR)
14.76%
Merck & Co., Inc.
6.30%
Bayer AG (ADR)
17.58%
PFE
Pfizer Inc
3.78%
Novartis AG (ADR)
3.53%
Roche Holding Ltd. (ADR)
3.11%
Merck & Co., Inc.
3.00%
Bayer AG (ADR)
2.34%
PFE
Pfizer Inc
0.03%
Novartis AG (ADR)
0.93%
Roche Holding Ltd. (ADR)
1.68%
-0.19%
Merck & Co., Inc.
Bayer AG (ADR)
4.08%
Compare these stocks

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

http://www.pfizer.com

Loading...

expand, down-facing arrow indicating expanded view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open33.96
Previous Close33.85
Day High34.02
Day Low33.77
52 Week High8/1/2016 | 37.39
52 Week Low11/3/2016 | 29.83
% Off 52 Week High(9.44)%
% Off 52 Week Low13.51%
Beta (5 Yr)1
Volatility Avg4/27/2017 | 15.78
10-Day Avg. Volume19,548,750
Market data is delayed by at least 15 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)12/31/2016 | 1.17
P/E Ratio12/31/2016 | 29.0
Market CapMega Cap | 201.6B
Shares Outstanding5.96B
Float6.0B

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield3.78%
Ex-Date2/1/2017
Dividend Announcement12/12/2016
Date of Record2/3/2017
Payable$0.32 - QRTR
Payable Date3/1/2017

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short50.04M
Short Ratio2.8
Short % of Float0.84%
As of 4/13/2017
The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance quoted. Investment return and principal value of an investment will fluctuate and when redeemed, the investment may be worth more or less than their original cost.
The research, tools, and information provided will not include every security available to the public.